[ET Net News Agency, 19 January 2024] CARDIOFLOW-B (02160) fell 3.7% to HK$1.3.
It hits an intra-day low of HK$1.3, hitting a historical low, and an intra-day high of
HK$1.35. The total shares traded was 927,000, with a value of HK$1.23m. The active
buy/sell ratio is 23:77, with net selling turnover of HK$631,800. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$207,782, with volume weighted
average price of HK$1.328. J.P. MORGAN BRO (HK) accounts for greatest net responsive
selling turnover of HK$66,235, with volume weighted average price of HK$1.339. The stock
has fallen a combined 18.2% over the past 6 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 1.300 % Chg -3.70%
High 1.350 Low 1.300
Shares Tr 927,000 Turnover 1.23m
10-D SMA 1.477 %H.V 39.421
20-D SMA 1.538 VWAP 1.326
50-D SMA 1.676 RSI14 22.487
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 23:77, with net selling
turnover of HK$631,800, falling a combined 18.2% over the past 6 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CARDIOFLOW-B (02160) 1.30 -3.70
GENSCRIPT BIO (01548) 16.58 -4.27
INNOVENT BIO (01801) 36.10 -9.18
JXR (01951) 2.45 -3.54
EVEREST MED-B (01952) 16.98 -5.25
WUXI BIO (02269) 28.05 -3.61
WUXI APPTEC (02359) 78.80 +0.51
BEIGENE (06160) 95.95 -4.34
ZAI LAB (09688) 17.68 -2.00
AKESO (09926) 41.50 -8.49
---------------------------------------------
(ed)